Submission Deadline: May 1, 2025

点此提交摘要>>>Submit Abstract>>>

Policies Governing Accepted Submissions:

1. Abstracts must be submitted online by May 1, 2025 to be eligible for review by the Program Committee.
2. Submission of a corrected abstract is not allowed after May 1, 2025.
3. Once an abstract is accepted, additional authors cannot be added.
4. An orthopaedic surgeon, resident and/or a member of COS must be listed as one of the authors. Presenters must be a medical student, resident/fellow or physician to present at the Annual Meeting.
5. Acceptance or rejection letters, and all future correspondence will be emailed to the Primary Contact listed on the Abstract Submission Form. Notification of acceptance will be sent in July 2025 to the email address provided on the submission form. Failure to complete Presenter Forms by the date listed, will result in the presentation being removed from the program.
6. Abstracts not accepted for a podium presentation may be accepted for an E-Poster presentation.
7. The paper is to be original, unpublished work.
8. All co-authors must complete a disclosure form, or your presentation will be eliminated from the meeting.
9. A copy of the manuscript may be requested for award consideration as determined by the Program Committee. The stipend for the award paper is contingent on the Resident/Fellow author, listed as the Primary Author on the Abstract Submission Form, presenting the paper at the Annual Meeting.
10. COS reserves the right to publish the accepted abstracts in a medical journal. This will not preclude publishing the manuscript in another journal.
11. The COS reserves the right to withdraw a presentation at any time.

Instructions to complete abstract submissions:

1. TITLE: Make the title brief and clearly indicate the nature of the study/procedure. Do not use all caps. Please do not use similar titles for numerous submissions.
2. CONTENT: The abstract must include four parts: INTRODUCTION should clearly state the problem and the purpose of the study; METHODS should provide a description of what was actually done; RESULTS should contain the findings of the study; DISCUSSION AND CONCLUSION should be based upon the findings and relate to the stated purpose of the study and existing knowledge. Provide specific details about your research/study. DO NOT list any author's name or institution in the abstract or manuscript. A two-year minimum follow-up per patient is required for all results for reconstructive procedures and new or modified techniques as they relate to diagnosis, surgery, complications or other phases of orthopaedic surgical problems.
3. LENGTH: The abstract should be typed on the form provided within space allotted (300 words max). Additional pages will not be accepted. Use English only.
4. STYLE: Use title case for the entire title: DO NOT include company names, titles, appointments or addresses in the abstract. DO NOT use subtitles. Standard abbreviations may be used, when necessary. Do not cite references. Omit P values. No reference is to be made in your text as to authors, institutions, clinics, pharmaceutical companies, or specific manufacturers. Submit the form, completed in full. Please check your work prior to submission. The Clinical Orthopaedic Society is not responsible for proofreading or accuracy.
5. DRUG NAMES: Nonproprietary (generic) names of drugs are required and should be written in lower case. Proprietary names are capitalized.
6. SUBMISSIONS: An Electronic Submission form is provided below for all submissions. The abstract submission deadline for COS' Annual Meeting is May 1, 2025.
7. NOTIFICATION OF ACCEPTANCE: The Program Committee will review Abstracts. You will be notified of acceptance by email by July 2025. The Clinical Orthopaedic Society reserves the right to withdraw a paper at any time.
8. REGISTRATION FEES: All presenters are required to register for the meeting and pay the registration fee.
9. MANUSCRIPT: The paper is to be original, unpublished work. Papers that have been previously published are ineligible. Papers that have been submitted for publication but will remain unpublished prior to the date of the Annual Meeting are eligible. If a paper is accepted but is subsequently found to have been published before the Annual Meeting, the Program Committee has the right to withdraw the paper.